文献速递造血干细胞移植与细胞治疗

CSF1R抑制在移植物抗宿主病小鼠中促进神经炎症和行为缺陷

CSF1R inhibition promotes neuroinflammation and behavioral deficits during graft-versus-host disease in mice.
PubMed 文献 · Blood · 2024-01-01

该研究探讨CSF1R抗体阻断在异基因造血干细胞移植后中枢神经系统慢性移植物抗宿主病(cGVHD)中的作用。研究发现移植后早期CSF1R阻断意外加重急性GVHD神经炎症,在已建立的cGVHD中疗效有限,且抗CSF1R抗体本身可导致非GVHD对照小鼠行为异常,提示正在进行的CSF1R抑制临床试验应评估神经不良事件。

要点

  • 移植后早期CSF1R阻断意外加重急性GVHD神经炎症。
  • 抗CSF1R治疗小鼠脑内保留供者BMDM、活化小胶质细胞及T细胞。
  • 非GVHD对照小鼠接受抗CSF1R抗体后出现行为异常。

核心结论

  • CSF1R阻断在移植后表现出意外的神经免疫毒性,并提示正在进行的CSF1R抑制临床试验应评估患者神经不良事件。
  • 转输Ifngr-/-移植物可减少MHC II+ BMDM浸润并改善神经认知功能,为中枢神经系统cGVHD治疗提供替代靶点。

研究设计与样本

  • 小鼠异基因造血干细胞移植模型研究,涉及急性GVHD和已建立的cGVHD阶段。

主要发现

  • 急性GVHD期间血脑屏障通透性增加,促进抗CSF1R抗体进入中枢神经系统并清除小胶质细胞。
  • 移植后早期CSF1R阻断意外加重急性GVHD神经炎症。
  • 在已建立的cGVHD中,血管变化和抗CSF1R疗效更为有限。
  • 抗CSF1R治疗小鼠脑内保留供者BMDM、活化小胶质细胞、CD8+和CD4+ T细胞及局部细胞因子表达。
  • 转输Ifngr-/-移植物可减少MHC II+ BMDM浸润,改善神经认知功能。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic graft-versus-host disease (cGVHD) remains a significant complication of allogeneic hematopoietic stem cell transplantation. Central nervous system (CNS) involvement is becoming increasingly recognized, in which brain-infiltrating donor major histocompatibility complex (MHC) class II+ bone marrow-derived macrophages (BMDM) drive pathology. BMDM are also mediators of cutaneous and pulmonary cGVHD, and clinical trials assessing the efficacy of antibody blockade of colony-stimulating factor 1 receptor (CSF1R) to deplete macrophages are promising. We hypothesized that CSF1R antibody blockade may also be a useful strategy to prevent/treat CNS cGVHD. Increased blood-brain barrier permeability during acute GVHD (aGVHD) facilitated CNS antibody access and microglia depletion by anti-CSF1R treatment. However, CSF1R blockade early after transplant unexpectedly exacerbated aGVHD neuroinflammation. In established cGVHD, vascular changes and anti-CSF1R efficacy were more limited. Anti-CSF1R-treated mice retained donor BMDM, activated microglia, CD8+ and CD4+ T cells, and local cytokine expression in the brain. These findings were recapitulated in GVHD recipients, in which CSF1R was conditionally depleted in donor CX3CR1+ BMDM. Notably, inhibition of CSF1R signaling after transplant failed to reverse GVHD-induced behavioral changes. Moreover, we observed aberrant behavior in non-GVHD control recipients administered anti-CSF1R blocking antibody and naïve mice lacking CSF1R in CX3CR1+ cells, revealing a novel role for homeostatic microglia and indicating that ongoing clinical trials of CSF1R inhibition should assess neurological adverse events in patients. In contrast, transfer of Ifngr-/- grafts could reduce MHC class II+ BMDM infiltration, resulting in improved neurocognitive function. Our findings highlight unexpected neurological immune toxicity during CSF1R blockade and provide alternative targets for the treatment of cGVHD within the CNS.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Adams RC, Carter-Cusack D, Llanes GT, et al. CSF1R inhibition promotes neuroinflammation and behavioral deficits during graft-versus-host disease in mice. Blood. 2024. PMID: 38048572. doi:10.1182/blood.2023022040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。